FiercePharma2d
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...
Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™
The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of ...
devdiscourse3d
Kennedy's Controversial Nomination: A Legal Fees Debate in the Health Sector
Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services has sparked debate due to his previously earned ...
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a ...
devdiscourse4d
Health Sector Headlines: Kennedy's Legal Fees, WHO Exit Impact, Biotech Deals, and More
This report covers recent health news, including Robert F. Kennedy Jr.'s legal fees from Merck litigations, rejections of a ...
AFP4d
Merck Partners with Opentrons Labworks, Inc., supporting Lab of the Future
Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom ...
Merck KGaA (OTCMKTS:MKGAF) Stock Crosses Below Fifty Day Moving Average – What’s Next?
Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $147.57 and traded as low as ...